Smile Doctors, Backed by THL and Linden, Pursues $2 Billion Debt Financing to Expand Dental Services

Smile Doctors, a rapidly growing dental services provider backed by Thomas H. Lee Partners (THL) and Linden Partners, is actively assessing a $2 billion debt financing package to support its national expansion and technology modernization. The initiative marks a significant financing milestone for a private healthcare company in the outpatient dental segment, reflecting strong confidence from institutional lenders and investors in the sector’s long-term growth trajectory. The proposed debt deal, while not yet finalized, is expected to include a mix of senior and secured notes, with maturities stretching into the 2030s. The funding would be deployed toward opening new clinics, enhancing digital infrastructure, and integrating patient care platforms across its network. This aligns with broader trends in healthcare services, where private equity firms are increasingly using debt to scale specialty providers amid rising demand for accessible, high-quality dental care. The move comes at a time of elevated capital market activity in healthcare services, with credit spreads remaining narrow for investment-grade healthcare issuers. The implied valuation multiple for Smile Doctors, though not disclosed, is believed to be in line with recent transactions in the dental and outpatient care space, where similar entities have traded at enterprise values exceeding $10 billion. The deal could also influence the broader market, particularly for healthcare-focused credit instruments such as XLV, HMO, and JNJ, whose performance may be indirectly affected by shifts in private sector financing trends. Stakeholders across the healthcare ecosystem—including private equity firms, hospital systems, and dental service organizations—are watching the transaction closely. A successful issuance could pave the way for additional debt-funded expansions in niche healthcare segments, reinforcing the sector’s appeal to capital markets.